Featured Publications
Drug and alcohol treatment utilization and barriers among Black, American Indian/Alaskan Native, Latine, Asian/Pacific Islander/Native Hawaiian, and White adults: Findings from NESARC-III
Haeny AM, Oluwoye O, Cruz R, Iheanacho T, Jackson AB, Fisher S, Crouch M, O'Malley S. Drug and alcohol treatment utilization and barriers among Black, American Indian/Alaskan Native, Latine, Asian/Pacific Islander/Native Hawaiian, and White adults: Findings from NESARC-III. Journal Of Substance Use And Addiction Treatment 2021, 131: 108569. PMID: 34393011, PMCID: PMC9084614, DOI: 10.1016/j.jsat.2021.108569.Peer-Reviewed Original ResearchConceptsAI/AN adultsAlcohol treatment utilizationAI/ANsTreatment utilizationAlcohol use disorderWhite adultsBlack adultsDUD treatmentLifetime alcohol use disorderAmerican Indians/Alaska NativesAmerican Indian/Alaskan NativeHealth care professionalsNational Epidemiological SurveyEthnic groupsNative HawaiiansOutpatient programEpidemiological dataCare professionalsUse disordersAUD treatmentEpidemiological surveySecondary analysisSocial determinantsRelated conditionsNESARC-III
2020
A Cross-Sectional Analysis of Tobacco Use and Concurrent Alcohol and Substance Use Among Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center
Sims OT, Jackson A, Guo Y, Truong DN, Odame EA, Mamudu HM. A Cross-Sectional Analysis of Tobacco Use and Concurrent Alcohol and Substance Use Among Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center. Journal Of Clinical Psychology In Medical Settings 2020, 28: 553-561. PMID: 33001329, PMCID: PMC7528154, DOI: 10.1007/s10880-020-09744-2.Peer-Reviewed Original ResearchConceptsHIV/HCVTobacco useConcurrent alcoholSubstance useHIV/HCV Co-infectionLarge urban tertiary centerHCV Co-InfectionUrban tertiary centerTreatment of HCVSubstance use disordersCross-sectional analysisTertiary centerTobacco smokersCo-InfectionClinical evaluationHCVUse disordersPatientsMultivariate analysisClinical interventionsBehavioral interventionsCOVID-19 pandemicPrevalenceHigher proportionIntervention
2019
The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice
Jackson AB, Toma W, Contreras KM, Alkhlaif Y, Damaj MI. The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice. Pharmacology Biochemistry And Behavior 2019, 183: 1-5. PMID: 31145916, PMCID: PMC7197262, DOI: 10.1016/j.pbb.2019.05.003.Peer-Reviewed Original ResearchConceptsNicotine withdrawal signsWithdrawal signsNicotine rewardNicotinic acetylcholine receptorsWT miceNicotine dependenceAcetylcholine receptorsNicotine dependence behaviorsNicotine-dependent miceAffective nicotine withdrawal signsΒ3 subunitTobacco use disorderNicotine-induced CPPSimilar somatic symptomsPlace preference testNew molecular targetsAffective withdrawal signsAddictive componentSpontaneous withdrawalWithdrawal studyKO miceFemale miceHealth burdenPhysical signsUse disorders